Alphatec Holdings, Inc. delivered a strong second quarter in 2025, with total revenue growing 27.5% to $186 million and surgical revenue increasing by 29% to $168 million. The company achieved non-GAAP net income profitability and significantly expanded its Adjusted EBITDA margin to 13%, reflecting disciplined execution and continued momentum in its procedural solutions.
Total revenue increased by 27.5% year-over-year, reaching $186 million in Q2 2025.
Surgical revenue grew by 29% to $168 million, driven by the continued adoption of PTP™ and LTP™.
The company achieved non-GAAP net income of $3 million, marking an inflection to profitability.
Adjusted EBITDA margin expanded significantly by 880 basis points year-over-year to 13%.
For the full fiscal year ending December 31, 2025, Alphatec has increased its total revenue guidance to $742 million, up from the previous expectation of $734 million. Non-GAAP adjusted EBITDA is now expected to be approximately $83 million, an increase from the prior expectation of $78 million.
Analyze how earnings announcements historically affect stock price performance